These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3384844)

  • 21. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC; Sidky YA; Hatcher JF; Bryan GT
    Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic antineoplastic and cytogenetic effects by the combined action of two homo-aza-steroidal esters of nitrogen mustards on P388 and L1210 leukaemias in vivo and in vitro.
    Nikolaropoulos S; Tsavdaridis D; Arsenou E; Papageorgiou A; Karaberis E; Mourelatos D
    Anticancer Res; 2000; 20(4):2745-51. PubMed ID: 10953353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity of homo-aza-steroidal esters of [p-[bis(2-chloroethyl)amino]phenyl]acetic acid and [p-[bis(2-chloroethyl)amino]phenyl]butyric acid.
    Catsoulacos P; Politis D; Wampler GL
    Cancer Chemother Pharmacol; 1983; 10(2):129-32. PubMed ID: 6831626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steroidal esters of the aromatic nitrogen mustard 2-[4-N,N-bis(2-chloroethyl)amino-phenyl]butanoic acid (2-PHE-BU): synthesis and in-vivo biological evaluation.
    Papaconstantinou IC; Fousteris MA; Koutsourea AI; Pairas GN; Papageorgiou AD; Nikolaropoulos SS
    Anticancer Drugs; 2013 Jan; 24(1):52-65. PubMed ID: 23187313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetic and antineoplastic effects by newly synthesised steroidal alkylators in lymphocytic leukaemia P388 cells in vivo.
    Mourelatos C; Kareli D; Dafa E; Argyraki M; Koutsourea A; Papakonstantinou I; Fousteris M; Pairas G; Nikolaropoulos S; Lialiaris TS
    Mutat Res; 2012 Jul; 746(1):1-6. PubMed ID: 22464985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of current alkylating agents with a homo-aza-steroidal ester for antineoplastic activity.
    Catsoulacos P; Papageorgiou A; Margarity E; Mourelatos D; Mioglou E
    Oncology; 1994; 51(1):74-8. PubMed ID: 8265107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination chemotherapy of early and advanced murine P388 leukaemia with bouvardin, cis-diamminedichloroplatinum and vincristine.
    Adwankar MK; Khandalekar DD; Chitnis MP
    Oncology; 1984; 41(5):370-3. PubMed ID: 6540853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of random screening of possible antineoplastic agents in Japan using mouse cancer. 3].
    Gan To Kagaku Ryoho; 1984 Sep; 11(9 Pt 2):1899-2096. PubMed ID: 6497404
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antineoplastic and curative antileukemic activity of 1,4-benzoquinone guanylhydrazone thiosemicarbazone and its hydrochloride on in vivo murine models].
    Gutsche W; Schulze W; Jungstand W; Wohlrabe K
    Pharmazie; 1983 Feb; 38(2):105-7. PubMed ID: 6856662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on high-dose chemotherapy of amygdalin in murine P388 lymphocytic leukaemia and P815 mast cell leukaemia.
    Chitnis MP; Adwankar MK; Amonkar AJ
    J Cancer Res Clin Oncol; 1985; 109(3):208-9. PubMed ID: 4008516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity of tetraacetylglucosamine mustard.
    Wampler GL; Nassiri SK; Hsiao YY; Bardos TJ; Regelson W
    Cancer Res; 1975 Aug; 35(8):1903-6. PubMed ID: 1149014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigations into the antitumour activity of organotin compounds. I. Diorganotin dihalide and di-pseudohalide complexes.
    Crowe AJ; Smith PJ; Atassi G
    Chem Biol Interact; 1980 Oct; 32(1-2):171-8. PubMed ID: 7428110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, hydrolytic reactivity, and anticancer evaluation of N- and O-triorganosilylated compounds as new types of potential prodrugs.
    Chiu FT; Chang YH; Ozkan G; Zon G; Fichter KC; Phillips LR
    J Pharm Sci; 1982 May; 71(5):542-51. PubMed ID: 7097502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antileukemic and cytogenetic activity by triple administration of three modified steroidal derivatives of nitrogen mustards.
    Fousteris MA; Papageorgiou A; Arsenou ES; Koutsourea AI; Karaberis E; Mourelatos D; Onyango DO; Nikolaropoulos SS
    Chemotherapy; 2007; 53(2):118-26. PubMed ID: 17308378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic effectiveness of PTT-119 evaluated in vivo in experimental models].
    Bianchi R; Nardelli B; Allegrucci M; Fioretti MC
    G Ital Chemioter; 1985; 32(1):1-6. PubMed ID: 3830770
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of the pretreatment with some cytostatic agents on the growth rate of leukaemia L5178Y.
    Bohunickå E; Koza I; Ujhåzy V
    Neoplasma; 1974; 21(6):659-63. PubMed ID: 4479976
    [No Abstract]   [Full Text] [Related]  

  • 37. Activity of a novel carotenoid analog, 4,4'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaen -1,18- diyl) bis(1-ethylpyridinium) dibromide (Y-18598) on mouse leukemia P388.
    Okumoto T; Morita N; Nakamura I; Konishi M; Yamaguchi M
    J Cancer Res Clin Oncol; 1985; 109(3):257-9. PubMed ID: 3839242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative antineoplastic activity against P388 leukemia of 9-beta-D-arabinofuranosyladenine (araA) and 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl) adenine (arazide).
    Lee SH; Thomas LK; Unger FM; Christian R; Sartorelli AC
    Int J Cancer; 1981 May; 27(5):703-8. PubMed ID: 6974703
    [No Abstract]   [Full Text] [Related]  

  • 39. Potential antitumor agents: steroidal amidoesters with an alkylating moiety.
    Papageorgiou A; Boutis L; Nicolaropoulos S; Catsoulacos P
    Oncology; 1987; 44(2):128-32. PubMed ID: 3574853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of intracellular pH in the development of resistance of leukemic cells to antineoplastic drugs].
    Shestova OL; Ogloblina TA; Litinskaia LL
    Eksp Onkol; 1990; 12(3):61-2. PubMed ID: 2344828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.